SGMT
Price:
$6.35
Market Cap:
$196.86M
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Industry
Biotechnology
IPO Date
2023-07-17
Stock Exchange
NASDAQ
Ticker
SGMT
According to Sagimet Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 164.48M. This represents a change of 30.83% compared to the average of 125.72M of the last 4 quarters.
The mean historical Enterprise Value of Sagimet Biosciences Inc. over the last ten years is 228.14M. The current 164.48M Enterprise Value has changed 7.11% with respect to the historical average. Over the past ten years (40 quarters), SGMT's Enterprise Value was at its highest in in the March 2022 quarter at 410.41M. The Enterprise Value was at its lowest in in the March 2024 quarter at -24874796.79.
Average
228.14M
Median
291.24M
Minimum
23.54M
Maximum
353.73M
Discovering the peaks and valleys of Sagimet Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 177.46%
Maximum Annual Enterprise Value = 353.73M
Minimum Annual Increase = -93.34%
Minimum Annual Enterprise Value = 23.54M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 65.32M | 177.46% |
| 2023 | 23.54M | -93.34% |
| 2022 | 353.73M | 18.98% |
| 2021 | 297.29M | 4.25% |
| 2020 | 285.18M | -17.05% |
The current Enterprise Value of Sagimet Biosciences Inc. (SGMT) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
147.53M
5-year avg
205.01M
10-year avg
228.14M
Sagimet Biosciences Inc.’s Enterprise Value is greater than Arcturus Therapeutics Holdings Inc. (26.78M), less than Humacyte, Inc. (196.00M), less than Assembly Biosciences, Inc. (282.59M), greater than Zura Bio Limited (113.92M), less than Voyager Therapeutics, Inc. (235.09M), less than Entrada Therapeutics, Inc. (347.42M), less than Foghorn Therapeutics Inc. (208.87M), less than Immuneering Corporation (220.51M), less than Achieve Life Sciences, Inc. (232.44M), greater than Atea Pharmaceuticals, Inc. (154.94M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 26.78M | $185.27M | |
| 196.00M | $185.66M | |
| 282.59M | $303.71M | |
| 113.92M | $252.94M | |
| 235.09M | $241.84M | |
| 347.42M | $388.31M | |
| 208.87M | $258.99M | |
| 220.51M | $242.86M | |
| 232.44M | $254.41M | |
| 154.94M | $241.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sagimet Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sagimet Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sagimet Biosciences Inc.'s Enterprise Value?
What is the highest Enterprise Value for Sagimet Biosciences Inc. (SGMT)?
What is the 3-year average Enterprise Value for Sagimet Biosciences Inc. (SGMT)?
What is the 5-year average Enterprise Value for Sagimet Biosciences Inc. (SGMT)?
How does the current Enterprise Value for Sagimet Biosciences Inc. (SGMT) compare to its historical average?